MedTrace Logo

Novel Markers for Detecting Early Progression of Glaucoma

NCT03108443 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2025-02-17

No results posted yet for this study

Summary

Current methods of detecting glaucoma and monitoring its progression over time involve visual assessment of the optic nerve, thickness measurements of nerve tissue in the eye (using optical coherence tomography, OCT) as well as functional tests which measure peripheral, or side, vision. The objective of this study is to determine if a new technique of measuring blood flow in the eye, using OCT, can be used to better detect and/or monitor changes in glaucoma patients and suspects than these methods.

Conditions

Interventions

DIAGNOSTIC_TEST

Optical Coherence tomography angiography

All subjects will have OCT angiography imaging performed

Sponsors & Collaborators

  • Balwantray Chauhan

    lead OTHER

Principal Investigators

  • Balwantray Chauhan, PHD · Nova Scotia Health Authority

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2026-05-31
Completion
2026-05-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03108443 on ClinicalTrials.gov